等待开盘 11-17 09:30:00 美东时间
+0.290
+0.50%
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
今日重点评级关注:花旗:维持Faeth Therapeutics"买入"评级,目标价从55美元升至60美元;HC Wainwright & Co.:维持Ocular Therapeutix"买入"评级,目标价从25美元升至28美元
11-11 10:50
RBC Capital analyst Michael Carroll maintains American Healthcare REIT (NYSE:AHR) with a Outperform and raises the price target from $61 to $66.
11-10 23:56
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• # American Healthcare REIT(AHR)2026年第三季度业绩回顾摘要 ## 1. 财务业绩:**核心盈利指标(Normalized FFO)** - 本季度标准化运营资金(Normalized FFO/NFFO)为每股摊薄0.58美元,同比增长31.8%,主要受益于增值性收购及投资组合的有机增长。 **同店净营业收入(Same-Store NOI)** - 整体投资组合同店NOI同比增长13.8%,较第二季度的13.2%进一步加速,为连续第11个季度实现双位数增长。 - SHOP(高级住宅运营物业)板块同店NOI同比增长28.
11-08 12:11
华盛资讯11月7日讯,American Healthcare REIT, Inc.公布2026财年Q3业绩,公司Q3营收7.42亿美元,同比增长29.5%,归母净利润0.32亿美元,同比下滑44.4%。
11-07 07:03
华盛资讯11月6日讯,American Healthcare REIT, Inc.公布2026财年Q3业绩,公司Q3营收7.42亿美元,同比增长29.5%,归母净利润0.32亿美元,同比下滑44.4%。
11-06 05:54
Raymond James analyst David Rodgers initiates coverage on American Healthcare REIT (NYSE:AHR) with a Strong Buy rating and announces Price Target of $62.
10-13 18:43
The Print American Healthcare REIT, Inc. (NYSE:AHR) has closed six of the eight senior housing communities in its $873 million Kensington Senior Living portfolio. The first closings total approximately $572 million and move most of the transaction from pending to completed. The six properties compri...
09-02 21:12
今日重点评级关注:杰富瑞:维持拜玛林制药"买入"评级,目标价从104美元升至105美元;RBC Capital:维持Shift4 Payments"跑赢大市"评级,目标价从63美元升至67美元
09-01 08:37
Barclays analyst Richard Hightower maintains American Healthcare REIT (NYSE:AHR) with a Overweight and raises the price target from $61 to $66.
08-31 20:48